Paper Details 
Original Abstract of the Article :
It has been reported that drug-drug interactions (DDIs) can affect the pharmacokinetics and pharmacodynamics of various oral drugs. To better understand the effects of azole antifungal drugs (ketoconazole, fluconazole, and itraconazole) on pyrotinib's pharmacokinetics, DDIs between pyrotinib and thr...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490176/

データ提供:米国国立医学図書館(NLM)

Drug-Drug Interactions: Exploring the Impact of Azole Antifungal Drugs on Pyrotinib Pharmacokinetics

The intricate world of drug-drug interactions requires careful consideration, especially when multiple medications are being used. This research delves into the potential interactions between pyrotinib, an anti-cancer drug, and three commonly used azole antifungal drugs: ketoconazole, fluconazole, and itraconazole. The study examines the impact of these antifungal drugs on the pharmacokinetics of pyrotinib, investigating their potential to alter the drug's absorption, distribution, metabolism, and excretion.

A Cautionary Tale: Ketoconazole and Fluconazole Show Significant Impact on Pyrotinib Pharmacokinetics

The study's findings raise important concerns regarding the potential for drug-drug interactions between pyrotinib and certain azole antifungals. The authors found that ketoconazole and fluconazole significantly decreased the metabolism of pyrotinib both in vitro and in vivo. This observation suggests that co-administration of these drugs with pyrotinib could lead to increased drug levels in the body, potentially increasing the risk of side effects.

Navigating Drug Interactions: A Call for Vigilance and Further Research

This study highlights the need for vigilance when prescribing pyrotinib in conjunction with azole antifungal drugs. The findings emphasize the importance of careful monitoring and dose adjustments to minimize the risk of adverse interactions. Further research is warranted to fully understand the implications of these interactions and to develop strategies for safe and effective co-administration.

Dr.Camel's Conclusion

This research serves as a reminder of the crucial role of drug-drug interactions in medication management. The findings highlight the potential for significant interactions between pyrotinib and certain azole antifungals, underscoring the need for careful consideration and monitoring when prescribing these medications together. It is essential to stay informed about potential drug interactions and to consult with a healthcare professional to ensure safe and effective medication management.

Date :
  1. Date Completed n.d.
  2. Date Revised 2022-09-28
Further Info :

Pubmed ID

36160438

DOI: Digital Object Identifier

PMC9490176

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.